Literature DB >> 24603371

Oral terbinafine and itraconazole treatments against dermatophytes appear not to favor the establishment of Fusarium spp. in nail.

Julie Verrier1, Olympia Bontems, Florence Baudraz-Rosselet, Michel Monod.   

Abstract

BACKGROUND: Fusarium onychomycoses are weakly responsive or unresponsive to standard onychomycosis treatments with oral terbinafine and itraconazole.
OBJECTIVE: To examine whether the use of terbinafine and itraconazole, which are highly effective in fighting Trichophyton onychomycoses, could be a cause of the high incidence of Fusarium nail infections.
METHODS: Polymerase chain reaction methods were used to detect both Fusarium spp. and Trichophyton spp. in nails of patients who had either received treatment previously or not.
RESULTS: No significant microbiological differences were found between treated and untreated patients. In 24 of 79 cases (30%), Fusarium spp. was detected in samples of patients having had no previous antifungal therapy and when Trichophyton spp. grew in culture.
CONCLUSION: Oral terbinafine and itraconazole treatments do not appear to favor the establishment of Fusarium spp. in onychomycosis.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24603371     DOI: 10.1159/000357764

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

Review 1.  Diagnosis of Dermatophytosis Using Molecular Biology.

Authors:  Julie Verrier; Michel Monod
Journal:  Mycopathologia       Date:  2016-08-01       Impact factor: 2.574

2.  Treatment of onychomycosis using a 1064-nm diode laser with or without topical antifungal therapy: a single-center, retrospective analysis in 56 patients.

Authors:  G C Weber; P Firouzi; A M Baran; E Bölke; H Schrumpf; B A Buhren; B Homey; P A Gerber
Journal:  Eur J Med Res       Date:  2018-10-24       Impact factor: 2.175

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.